Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 21, 2012 - Issue 7
Submit an article Journal homepage
987
Views
18
CrossRef citations to date
0
Altmetric
Reviews

Beyond bevacizumab: new anti-VEGF strategies in colorectal cancer

Teresa TroianiOncologia Medica, Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale F. Magrassi e A. Lanzara, Seconda Università degli Studi di Napoli, Via S. Pansini 5, 80131 Napoli, [email protected]
,
Erika MartinelliOncologia Medica, Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale F. Magrassi e A. Lanzara, Seconda Università degli Studi di Napoli, Via S. Pansini 5, 80131 Napoli, [email protected]
,
Michele OrdituraOncologia Medica, Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale F. Magrassi e A. Lanzara, Seconda Università degli Studi di Napoli, Via S. Pansini 5, 80131 Napoli, [email protected]
,
Ferdinando De VitaOncologia Medica, Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale F. Magrassi e A. Lanzara, Seconda Università degli Studi di Napoli, Via S. Pansini 5, 80131 Napoli, [email protected]
,
Fortunato CiardielloOncologia Medica, Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale F. Magrassi e A. Lanzara, Seconda Università degli Studi di Napoli, Via S. Pansini 5, 80131 Napoli, [email protected]
&
Floriana MorgilloOncologia Medica, Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale F. Magrassi e A. Lanzara, Seconda Università degli Studi di Napoli, Via S. Pansini 5, 80131 Napoli, [email protected]
Pages 949-959 | Published online: 22 May 2012

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Anuj Patel & Weijing Sun. (2014) Ziv-aflibercept in metastatic colorectal cancer. Biologics: Targets and Therapy 8, pages 13-25.
Read now
Erika Martinelli, Teresa Troiani, Floriana Morgillo, Michele Orditura, Fernando De Vita, Giulio Belli & Fortunato Ciardiello. (2013) Emerging VEGF-receptor inhibitors for colorectal cancer. Expert Opinion on Emerging Drugs 18:1, pages 25-37.
Read now

Articles from other publishers (16)

Chao Chen, Songtao Hou, Fei Zhao, Bin Wu, Tingting Liu, Zhao Zhang, Yuwei Li & Hongchao Li. (2022) Application of Bevacizumab Combined With Chemotherapy in Patients With Colorectal Cancer and Its Effects on Brain-Gut Peptides, Intestinal Flora, and Oxidative Stress. Frontiers in Surgery 9.
Crossref
Ranmali Ranasinghe, Michael Mathai & Anthony Zulli. (2022) A synopsis of modern - day colorectal cancer: Where we stand. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877:2, pages 188699.
Crossref
Erika Correa, Timothy Lindsay & Efrat Dotan. (2021) Management of Metastatic Colorectal Carcinoma in Older Adults: Balancing Risks and Benefits of Novel Therapies. Drugs & Aging 38:8, pages 639-654.
Crossref
Ana I. Matos, Barbara Carreira, Carina Peres, Liane I.F. Moura, João Conniot, Thibaut Fourniols, Anna Scomparin, Águeda Martínez-Barriocanal, Diego Arango, João P. Conde, Véronique Préat, Ronit Satchi-Fainaro & Helena F. Florindo. (2019) Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer. Journal of Controlled Release 307, pages 108-138.
Crossref
Jinqiu Wang, Yang Lu, Yiyong Zeng, Leming Zhang, Kongliang Ke & Yu Guo. (2018) Expression profile and biological function of miR‑455‑5p in colorectal carcinoma. Oncology Letters.
Crossref
Miriam Canavese, Doan T.M. Ngo, Guy J. Maddern, Jennifer E. Hardingham, Timothy J. Price & Ehud Hauben. (2017) Biology and therapeutic implications of VEGF-A splice isoforms and single-nucleotide polymorphisms in colorectal cancer. International Journal of Cancer 140:10, pages 2183-2191.
Crossref
Thomas J. Semrad, Edward J. Kim, Michael S. Tanaka, Jacob Sands, Chris Roberts, Rebekah A. Burich, Yu Li, David R. Gandara, Primo LaraJr.Jr. & Philip C. Mack. (2017) Phase II study of dovitinib in patients progressing on anti-vascular endothelial growth factor therapy. Cancer Treatment and Research Communications 10, pages 21-26.
Crossref
Edward M. BarksdaleJr.Jr. & Iuliana D. Bobanga. 2016. The Surgery of Childhood Tumors. The Surgery of Childhood Tumors 681 710 .
Bao-Jun Ren, Zhi-Wei Zhou, Da-Jian Zhu, Yong-Le Ju, Jin-Hao Wu, Man-Zhao Ouyang, Xiao-Wu Chen & Shu-Feng Zhou. (2015) Alisertib Induces Cell Cycle Arrest, Apoptosis, Autophagy and Suppresses EMT in HT29 and Caco-2 Cells. International Journal of Molecular Sciences 17:1, pages 41.
Crossref
Roberta Schmieder, Jens Hoffmann, Michael Becker, Ajay Bhargava, Tina Müller, Nicole Kahmann, Peter Ellinghaus, Robert Adams, André Rosenthal, Karl‐Heinz Thierauch, Arne Scholz, Scott M. Wilhelm & Dieter Zopf. (2014) Regorafenib (BAY 73‐4506): Antitumor and antimetastatic activities in preclinical models of colorectal cancer. International Journal of Cancer 135:6, pages 1487-1496.
Crossref
Antonio Rossi, Valter Torri, Marina Chiara Garassino, Luca Porcu & Domenico Galetta. (2014) The impact of personalized medicine on survival: Comparisons of results in metastatic breast, colorectal and non-small-cell lung cancers. Cancer Treatment Reviews 40:4, pages 485-494.
Crossref
Natalie J. Carter. (2013) Regorafenib: A Review of Its Use in Previously Treated Patients with Progressive Metastatic Colorectal Cancer. Drugs & Aging 31:1, pages 67-78.
Crossref
Nikos Gavalas, Michalis Liontos, Sofia-Paraskevi Trachana, Tina Bagratuni, Calliope Arapinis, Christine Liacos, Meletios Dimopoulos & Aristotle Bamias. (2013) Angiogenesis-Related Pathways in the Pathogenesis of Ovarian Cancer. International Journal of Molecular Sciences 14:8, pages 15885-15909.
Crossref
Lotfi Abou-Elkacem, Susanne Arns, Gunnar Brix, Felix Gremse, Dieter Zopf, Fabian Kiessling & Wiltrud Lederle. (2013) Regorafenib Inhibits Growth, Angiogenesis, and Metastasis in a Highly Aggressive, Orthotopic Colon Cancer Model. Molecular Cancer Therapeutics 12:7, pages 1322-1331.
Crossref
Min Zheng, Jian Jiang, Ya-ling Tang & Xin-hua Liang. (2013) Oncogene and non-oncogene addiction in inflammation-associated cancers. Future Oncology 9:4, pages 561-573.
Crossref
K. Miura, W. Fujibuchi & M. Unno. (2012) Splice isoforms as therapeutic targets for colorectal cancer. Carcinogenesis 33:12, pages 2311-2319.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.